Cargando…
Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype
Centronuclear myopathy (CNM) is a congenital myopathy that is histopathologically characterized by centrally located nuclei, central aggregation of oxidative activity, and type I fiber predominance and hypotrophy. Here, we obtained commercially available mice overexpressing phospholamban (Pln(OE)),...
Autores principales: | Fajardo, Val A., Bombardier, Eric, McMillan, Elliott, Tran, Khanh, Wadsworth, Brennan J., Gamu, Daniel, Hopf, Andrew, Vigna, Chris, Smith, Ian C., Bellissimo, Catherine, Michel, Robin N., Tarnopolsky, Mark A., Quadrilatero, Joe, Tupling, A. Russell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527296/ https://www.ncbi.nlm.nih.gov/pubmed/26035394 http://dx.doi.org/10.1242/dmm.020859 |
Ejemplares similares
-
Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice
por: Fajardo, Val A., et al.
Publicado: (2017) -
Co-Expression of SERCA Isoforms, Phospholamban and Sarcolipin in Human Skeletal Muscle Fibers
por: Fajardo, Val A., et al.
Publicado: (2013) -
Diaphragm assessment in mice overexpressing phospholamban in slow‐twitch type I muscle fibers
por: Fajardo, Val Andrew, et al.
Publicado: (2016) -
A dog model for centronuclear myopathy carrying the most common DNM2 mutation
por: Böhm, Johann, et al.
Publicado: (2022) -
Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008)